Stockreport

Galectin Therapeutics' (GALT) Management Discusses Phase 2b NASH-CX Trial Results Conference Call (Transcript) [Seeking Alpha]

Galectin Therapeutics Inc.  (GALT) 
Last galectin therapeutics inc. earnings: 11/12 08:00 am Check Earnings Report
PDF Galectin Therapeutics, Inc. (NASDAQ: GALT ) Galectin Therapeutics Phase 2b NASH-CX Trial Results Presentation December 05, 2017 08:30 AM ET Executives Pete [Read more]